Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Diluted Average) (2022 - 2025)

Abeona Therapeutics has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $66.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $66.1 million for Q4 2025, up 61.12% from a year ago — trailing twelve months through Dec 2025 was $66.1 million (up 61.12% YoY), and the annual figure for FY2025 was $66.1 million, up 61.12%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $66.1 million at Abeona Therapeutics, up from $65.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ABEO hit a ceiling of $66.1 million in Q4 2025 and a floor of $5.8 million in Q2 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $27.3 million (2024), compared with a mean of $33.4 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 210.61% in 2023 and later rose 27.1% in 2025.
  • Abeona Therapeutics' Shares Outstanding (Diluted Average) stood at $7.9 million in 2022, then surged by 171.96% to $21.4 million in 2023, then soared by 91.99% to $41.0 million in 2024, then skyrocketed by 61.12% to $66.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $66.1 million (Q4 2025), $65.8 million (Q3 2025), and $65.1 million (Q2 2025) per Business Quant data.